Flow Cytometry-Based Pharmacodynamic Monitoring After Organ Transplantation

Methods in Cell Biology

Volumn 103, Issue , 2011, Pages 267-284

  Dieterlen, Maja Theresa ^a   Eberhardt, Katja ^a   Tarnok, Attila ^a   Bittner, Hartmuth B ^a   Barten, Markus J ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Dendritic cell; Graft; Immunosuppressive; Organ transplantation; Pharmacodynamic; Survival

Indexed keywords

CYCLOSPORIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN; TACROLIMUS;

BIOSYNTHESIS; BLOOD; BOOK; CYTOLOGY; DENDRITIC CELL; DRUG EFFECT; DRUG INTERACTION; DRUG MONITORING; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; IMMUNOLOGY; METHODOLOGY; ORGAN TRANSPLANTATION; T LYMPHOCYTE;

ANTIGENS, CD; CYCLOSPORINE; CYTOKINES; DENDRITIC CELLS; DRUG INTERACTIONS; DRUG MONITORING; FLOW CYTOMETRY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; T-LYMPHOCYTES; TACROLIMUS;

EID: 79959730233     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385493-3.00011-5     Document Type: Book

References (74)

1. Albert M.H., Anasetti C., Yu X.-Z. T regulatory cells as an immunotherapy for transplantation. Expert Opin. Biol. Ther. 2006, 6(4):315-324.
2. Alonso-Arias R., Suárez-Alvarez B., López-Vázquez A., Moro M..A., Baltar J., Gómez-Huertas E., Ortega T., Ortega F., López-Larrea C. CD127(low) expression in CD4+CD25(high) T cells as immune biomarker of renal function in transplant patients. Transplantation 2009, 88(3 Suppl):S85-S93. http://www.ncbi.nlm.nih.gov/pubmed/19667968.
3. Athanassopoulos P., Vaessen L.M.B., Balk A.H.M.M., Takkenberg J.J.M., Maat A.P.W.M., Weimar W., Bogers A.D.J.J.C. Impaired circulating dendritic cells reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy. Eur. J. Cardiothorac. Surg. 2005, 27:783-789.
4. Athanassopoulos P., Vaessen L.M.B., Maat A.P.W.M., Balk A.H.M.M., Weimar W., Bogers A.D.J.J.C. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses. Eur. J. Cardiothorac. Surg. 2004, 25:619-626.
5. Autissier P., Soulas C., Burdo T.H., Williams K.C. Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry A 2010, 77(5):410-419.
6. Baecher-Allan C. Human CD25high Tregs: isolation by beads versus by FACS sorting. Clin. Immunol. 2006, 120(2):234-235.
7. Barten M.J., Garbade J., Bittner H.B., Fiedler M., Dhein S., Thiery J., Mohr F.W., Gummert J.F. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation. Int. Immunopharmacol. 2006, 6:2011-2017.
8. Barten M.J., Gummert J.F. Biomarkers in transplantation medicine: prediction of pharmacodynamic drug effects. Transfus. Med. Hemother. 2007, 34:182-187.
9. Barten M.J., Rahmel A., Bocsi J., Boldt A., Garbade J., Dhein S., Mohr F.W., Gummert J.F. Cytokine analysis to predict immunosuppression. Cytometry A 2006, 69(3):155-157.
10. Barten M.J., Rahmel A., Garbade J., Bold A., Bittner H.B., Dhein S., Mohr F.W., Gummert J.F. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients. Transplant Proc. 2005, 37(10):4532-4534.
11. Barten M.J., Rahmel A., Garbade J., Richter M., Bittner H.B., Dhein S., Mohr F.W., Gummert J.F. C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipients. Transplant Proc. 2005, 37(2):1360-1361.
12. Barten M.J., Tarnok A., Garbade J., Bittner H.B., Dhein S., Mohr F.W., Gummert J.F. Pharmacodynamics of T-cell function for monitoring immunosuppression. Cell Prolif. 2007, 40(1):50-63.
13. Battaglia M., Stabilini A., Roncarolo M.G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005, 105(12):4743-4748.
14. Benitez F., Najafian N. Novel noninvasive assays to predict transplantation rejection and tolerance: enumeration of cytokine-producing alloreactive T cells. Clin. Lab. Med. 2008, 28:365-373.
15. Berry V., Magill A., Yost M., Janosky J., Sindhi R. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses. Cytometry A 2006, 69(2):95-103.
16. Billingham R.E., Brent L., Medawar P.B. Actively acquired tolerance of foreign cells. Nature 1953, 172(4379):603-606.
17. Böhler T., Canivet C., Galvani S., Therville N., Salvayre R., Negre-Salvayre A., Durand D., Thomsen M., Rostaing L., Kamar N. Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients. Int. Immunopharmacol. 2008, 8(5):769-773.
18. Böhler T., Nolting J., Kamar N., Gurragchaa P., Reisener K., Glander P., Neumayer H.H., Budde K., Klupp J. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans. Ther. Drug Monit. 2007, 29(1):77-86.
19. Boldt A., Barten M.J., Weiss C., Sagner A., Mohr F.W., Gummert J.F. Novel apoptosis assay to analyze immunosuppression. Cytometry A 2006, 69(3):158-160.
20. Bremer S., Vethe N.T., Rootwelt H., Jørgensen P.F., Stenstrøm J., Holdaas H., Midtvedt K., Bergan S. Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study. J. Trans. Med. 2009, 7:64.
21. Brown K.L., Palyvoda O.Y., Thakur J.S., Nehlsen-Cannarella S.L., Fagoaga O.R., Gruber S.A., Auner G.W. Differentiation of alloreactive versus CD3/CD28 stimulated T-lymphocytes using Raman spectroscopy: a greater specificity for noninvasive acute renal allograft rejection detection. Cytometry A 2009, 75(11):917-923.
22. Calvo-Turrubiartes M., Romano-Moreno S., García-Hernández M., Chevaile-Ramos J.A., Layseca-Espinosa E., González-Amaro R., Portales-Pérez D. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level. Transplant Immunol. 2009, 21(1):43-49.
23. Chen J., Gao J., Zhang D., Wang Z., Zhu J. CD4+FOXP3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25- naive T cells display more potent regulatory ability in vitro. Chin. Med. J. 2010, 123(7):942-948.
24. Chow S., Hedley D., Grom P., Magari R., Jacobberger J.W., Shankey T.V. Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry in intracellular phosphorylated epitopes in leukocyte subpopulations. Cytometry A 2005, 67A:4-17.
25. Clutter M.R., Heffner G.C., Krutzik P.O., Sachen K.L., Nolan G.P. Tyramide signal amplification for analysis of kinase activity by intracellular flow cytometry. Cytometry A 2010, 77(11):1020-1031.
26. Coenen J.J., Koenen H.J., van Rijssen E., Hilbrands L.B., Joosten I. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. Blood 2006, 107(3):1018-1023.
27. Couzi L., Thiébaut R., Carron J.C., Moreau J.F., Merville P., Taupin J.L. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients. Transplantation 2008, 86(8):1060-1067.
28. Cunnusamy K., Chen P.W., Niederkorn J.Y. IL-17 promotes immune privilege of corneal allografts. J. Immunol. 2010.
29. Dahl M.E., Berson A., Lora J., Fuentes M. A novel CCR5-specific pharmacodynamic assay in whole blood using phosphoflow cytometry highlights different ligand-dependent responses but similar properties of antagonists in CD8+ and CD4+ T lymphocytes. J. Pharm. Exp. Ther. 2008, 327(3):926-933.
30. Daniel V., Naujokat C., Sadeghi M., Wiesel M., Hergesell O., Opelz G. Association of circulating interleukin (IL)-12- and IL-10-producing dendritic cells with time posttransplant, dose of immunosuppression, and plasma cytokines in renal-transplant recipients. Transplantation 2005, 79(11):1498-1506.
31. Demirkiran A., Kok A., Kwekkeboom J., Metselaar H.J., Tilanus H.W., van der Laan L.J. Decrease of CD4+CD25+ T cells in peripheral blood after liver transplantation: association with immunosuppression. Transplant Proc. 2005, 37(2):1194-1196.
32. Fangmann J., Wegmann C., Hoppe A., Martin P., Sack U., Harms J., Faber S., Emmrich F. Characterization of dendritic cell subsets in patients undergoing renal transplantation. Transplant Proc. 2007, 39:3101-3104.
33. Galante N.Z., Câmara N.O., Kallas E.G., Salomão R., Pacheco-Silva A., Medina-Pestana J.O. Noninvasive immune monitoring assessed by flow cytometry and real time RT-PCR in urine of renal transplantation recipients. Transplant Immunol. 2006, 16(2):73-80.
34. Gerrit J.H., Athanassopoulos P., Vaessen L.M.B., Klepper M., Weimar W., van Besouw N.M. Peripheral blood manipulation significantly affects the result of dendritic cell monitoring. Transplant Immunol. 2007, 17:169-177.
35. Giannelli S., Taddeo A., Presicce P., Villa M.L., Bella S.D. A six-color flow cytometric assay for the analysis of peripheral blood dendritic cells. Cytometry B 2008, 74B:349-355.
36. Grant J., Bourcier K., Wallace S., Pan D., Conway A., Seyfert-Margolis V., Wallace P.K. Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients. Cytometry B 2009, 76(2):69-78.
37. Hackstein H., Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 2004, 4(1):24-34.
38. Hernandez-Fuentes M.P., Salama A. In vitro assays for immune monitoring in transplantation. Methods Mol. Biol. 2006, 333:269-290.
39. Hesselink D.A., Betjes M.G., Verkade M.A., Athanassopoulos P., Baan C.C., Weimar W. The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells. Nephrol. Dial. Transplant 2005, 20(9):1868-1873.
40. Hodge G., Hodge S., Reynolds P., Holmes M. Intracellular cytokines in blood T cells in lung transplant patients - a more relevant indicator of immunosuppression than drug levels. Clin. Exp. Immunol. 2005, 139(1):159-164.
41. Issa F., Schiopu A., Wood K.J. Role of T cells in graft rejection and transplantation tolerance. Expert Rev. Clin. Immunol. 2010, 6(1):155-169.
42. Kamar N., Glander P., Nolting J., Böhler T., Hambach P., Liefeldt L., Rostaing L., Neumayer H.H., Budde K. Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantation. Clin. J. Am. Soc. Nephrol. 2009, 4(5):936-942.
43. Kawai M., Kitade H., Mathieu C., Waer M., Pirenne J. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 2005, 79(9):1073-1077.
44. Kim S.H., Oh E.J., Ghee J.Y., Song H.K., Han D.H., Yoon H.E., Choi B.S., Yoon S.K., Choi J.Y., Moon I.S., Kim D.G., Yang C.W. Clinical significance of monitoring circulating CD4+CD25+ regulatory T cells in kidney transplantation during the early posttransplant period. J. Korean Med. Sci. 2009, 24(Suppl.):S135-S142.
45. Korczak-Kowalska G., Wierzbicki P., Bocian K., Klosowska D., Niemczyk M., Wyzgal J., Korecka A., Durlik M., Chmura A., Paczek L., Górski A. The influence of immunosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. Transplant Proc. 2007, 39(9):2721-2723.
46. Lanza F. Toward standardization of Foxp3+ regulatory T-cell measurement in clinical settings. Cytom. B Clin. Cytom. 2009, 76(2):67-68.
47. Le N.T., Chao N. Regulating regulatory T cells. Bone Marrow Transplant. 2007, 39:1-9.
48. Levy G.A. Progress in transplantation. Ther. Drug Monit. 2010, 32(3):246-249.
49. Lewkowicz P., Lewkowicz N., Sasiak A., Tchórzewski H. Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J. Immunol. 2006, 177(10):7155-7163.
50. Lim D.G., Koo S.K., Park Y.H., Kim Y., Kim H.M., Park C.S., Kim S.C., Han D.J. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation. Transplantation 2010, 89(8):928-936.
51. Lin C.C., Huang W.L., Su W.P., Chen H.H., Lai W.W., Yan J.J., Su W.C. Single cell phospho-specific flow cytometry can detect dynamic changes of phospho-Stat1 level in lung cancer cells. Cytometry A 2010, 77(11):1008-1019.
52. Lindsey W.B., Lowdell M.W., Marti G.E., Abbasi F., Zenger V., King K.M., Lamb L.S. CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery. Cytotherapy 2007, 9(2):123-132.
53. Magyarics Z., Csillag A., Pazmandi K., Rajnavolgyi E., Bacsi A. Identification of plasmacytoid pre-dendritic cells by one-color flow cytometry for phenotype screening. Cytometry A 2008, 73A:254-258.
54. McLaughlin B.E., Baumgarth N., Bigos M., Roederer M., De Rosa S.C., Altman J.D., Nixon D.F., Ottinger J., Li J., Beckett L., Shacklett B.L., Evans T.G., Asmuth D.M. Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: panel performance across different instrument platforms. Cytometry A 2008, 73(5):411-420.
55. McLaughlin B.E., Baumgarth N., Bigos M., Roederer M., De Rosa S.C., Altman J.D., Nixon D.F., Ottinger J., Oxford C., Evans T.G., Asmuth D.M. Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: panel design by an empiric approach. Cytometry A 2008, 73(5):400-410.
56. Miroux C., Moralès O., Carpentier A., Dharancy S., Conti F., Boleslowski E., Podevin P., Auriault C., Pancré V., Delhem N. Inhibitory effects of cyclosporine on human regulatory T cells in vitro. Transplant Proc. 2009, 41(8):3371-3374.
57. Naumann U., Wand M.P. Automation in high-content flow cytometry screening. Cytometry A 2009, 75(9):789-797.
58. Nickel P., Bestard O., Volk H.D., Reinke P. Diagnostic value of T-cell monitoring assays in kidney transplantation. Curr. Opin. Organ Transplant 2009, 14(4):426-431.
59. Oellerich M., Barten M.J., Armstrong V.W. Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics. Ther. Drug Monit. 2006, 28:35-38.
60. Panigrahi A., Deka R., Bhowmik D., Dash S.C., Tiwari S.C., Guleria S., Mehta S.N., Mehra N.K. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation. Clin. Transplant 2006, 20(1):85-90.
61. Peters J.H., Koenen H.J., Hilbrands L.B., Joosten I. Immunotherapy with regulatory T cells in transplantation. Immunotherapy 2009, 1(5):855-871.
62. Quaedackers M.E., Mol W., Korevaar S.S., van Gurp E.A., van Ijcken W.F., Chan G., Weimar W., Baan C.C. Monitoring of the immunomodulatory effect of CP-690550 by analysis of the JAK/STAT pathway in kidney transplant patients. Transplantation 2009, 88(8):1002-1009.
63. Ramírez E., Morales J.M., Lora D., Mellado M., Cevey M., Alfaro F.J., De Pablos P., Andrés A., Paz-Artal E., Serrano A. Peripheral blood regulatory T cells in long-term kidney transplant recipients. Transplant Proc. 2009, 41(6):2360-2362.
64. San Segundo D., Fábrega E., López-Hoyos M., Pons F. Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors. Transplant Proc. 2007, 39(7):2290-2292.
65. Segundo D.S., Ruiz J.C., Izquierdo M., Fernández-Fresnedo G., Gómez-Alamillo C., Merino R., Benito M.J., Cacho E., Rodrigo E., Palomar R., López-Hoyos M., Arias M. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Transplantation 2006, 82(4):550-557.
66. Serban G., Whittaker V., Fan J., Liu Z., Manga K., Khan M., Kontogianni K., Padmanabhan A., Cohen D., Suciu-Foca N., Ratner L., Colovai A.I. Significance of immune cell function monitoring in renal transplantation after thymoglobulin induction therapy. Hum. Immunol. 2009, 70(11):882-890.
67. Solari M.G., Thomson A.W. Human dendritic cells and transplant outcome. Transplantation 2008, 85:1513-1522.
68. Taams L.S., van Amelsfort J.M., Tiemessen M.M., Jacobs K.M., de Jong E.C., Akbar A.N., Bijlsma J.W., Lafeber F.P. Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum. Immunol. 2005, 66(3):222-230.
69. Thomson A.W., Robbins P.D. Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann. Rheum. Dis. 2008, 67:90-96.
70. Trzonkowski P., Szaryńska M., Myśliwska J., Myśliwski A. Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy. Cytometry A 2009, 75(3):175-188.
71. Trzonkowski P., Szmit E., Myśliwska J., Myśliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin. Immunol. 2006, 119(3):307-316.
72. van Rossum H.H., de Fijter J.W., van Pelt J. Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives. Ther. Drug Monit. 2010, 32(1):3-10.
73. Womer K.L., Peng R., Patton P.R., Murawski M.R., Bucci M., Kaleem A., Schold J., Efron P.A., Hemming A.W., Srinivas T.R., Meier-Kriesche H.U., Kaplan B., Clare-Salzler M.J. The effect of renal transplantation on peripheral blood dendritic cells. Clin. Transplant. 2005, 19(5):659-667.
74. Xue F., Zhang J., Han L., Li Q., Xu N., Zhou T., Xi Z., Wu Y., Xia Q. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. Transplantation 2010, 89(5):620-626.